Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad21d5ee105046bfd8d663df3e902de9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07b71571160c289fbf5fc680dfea513f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa44df13b55efa63d669e977516ee67b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93c53e73ee428304b11898666cb8a442 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0bfac7987b726ca402746a551e7ace73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b79e80b700edb181c05403a3bf08c27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65292346d55312afe72919289acb22f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b52c3ff9260ebeea82089a62dabc1543 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535 |
filingDate |
2008-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10df18831870752d1216625392919442 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_199b14da99109d0cfa3fdb230510eddf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27927c7933658fd829b8719d8d9751cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0a8da8e1f9079b135a9f160ee66226c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b880b39f7ceb9fbd3f47591e6e1cae43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc8dd829f6a8712a5603c277a3f97813 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b5283a88ef074a77b6032182535a2eb |
publicationDate |
2008-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2008086158-A1 |
titleOfInvention |
Benzodihydroquinazoline as pi3 kinase inhibitors |
abstract |
Invented are novel benzodihydroquinazoline compounds useful for inhibiting the activity/function of PI3 kinases and treating cancer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106188029-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113354630-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102212096-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150097511-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016501901-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11535600-B2 |
priorityDate |
2007-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |